###begin article-title 0
Mast cell-specific Cre/loxP-mediated recombination in vivo
###end article-title 0
###begin p 1
###xml 343 370 343 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mast cell protease (Mcpt) 5</italic>
###xml 381 390 381 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 691 696 691 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 783 792 783 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 190 195 <span type="species:ncbi:10090">mouse</span>
###xml 391 406 <span type="species:ncbi:10090">transgenic mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
Mast cells are important effectors of type I allergy but also essential regulators of innate and adaptive immune responses. The aim of this study was to develop a Cre recombinase-expressing mouse line that allows mast cell-specific inactivation of genes in vivo. Following a BAC transgenic approach, Cre was expressed under the control of the mast cell protease (Mcpt) 5 promoter. Mcpt5-Cre transgenic mice were crossed to the ROSA26-EYFP Cre excision reporter strain. Efficient Cre-mediated recombination was observed in mast cells from the peritoneal cavity and the skin while only minimal reporter gene expression was detected outside the mast cell compartment. Our results show that the Mcpt5 promoter can drive Cre expression in a mast cell-specific fashion. We expect that our Mcpt5-Cre mice will be a useful tool for the investigation of mast cell biology.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2002</xref>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">1997</xref>
###xml 264 269 264 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2005a</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">b</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2004</xref>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2007</xref>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">1996</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">1996</xref>
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2006</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">2000</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">2006</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2006</xref>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1992</xref>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2002</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2000</xref>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2007</xref>
Mast cells are central effector cells in type I allergy (Kawakami and Galli 2002; Metcalfe et al. 1997), but have recently been shown to be important initiators and effectors also of innate immunity as well as modulators of adaptive immune responses (Galli et al. 2005a, b; Marshall and Jawdat 2004). Many reports demonstrated a role of mast cells in host defence against pathogens (Dawicki and Marshall 2007; Echtenacher et al. 1996; Malaviya et al. 1996) and implicated a function of these cells in wound healing, tissue remodeling and transplant tolerance (Lu et al. 2006; Trautmann et al. 2000; Weller et al. 2006). A pathogenic role of mast cells was discussed in rheumatoid arthritis, systemic sclerosis, multiple sclerosis and atherosclerosis (Bachelet et al. 2006; Irani et al. 1992; Lee et al. 2002; Secor et al. 2000; Sun et al. 2007).
###end p 4
###begin p 5
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">1978</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">1985</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2002</xref>
###xml 575 580 575 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">2000)</xref>
###xml 679 682 679 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kit</italic>
###xml 682 687 682 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W/W-v</italic>
###xml 682 687 682 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>W/W-v</italic></sup>
###xml 692 695 692 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kit</italic>
###xml 695 704 695 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W-sh/W-sh</italic>
###xml 695 704 695 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>W-sh/W-sh</italic></sup>
###xml 791 794 791 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kit</italic>
###xml 955 960 955 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2005b</xref>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2005</xref>
###xml 1027 1030 1027 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kit</italic>
###xml 1030 1035 1030 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W/W-v</italic>
###xml 1030 1035 1030 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>W/W-v</italic></sup>
###xml 1260 1265 1260 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2005b</xref>
###xml 1268 1271 1268 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kit</italic>
###xml 1271 1275 1271 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W-sh</italic>
###xml 1271 1275 1271 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>W-sh</italic></sup>
###xml 1324 1327 1324 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kit</italic>
###xml 1327 1332 1327 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W/W-v</italic>
###xml 1327 1332 1327 1332 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>W/W-v</italic></sup>
###xml 1475 1479 1475 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2005</xref>
###xml 1498 1506 1498 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vitro</italic>
###xml 1851 1855 1851 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2005</xref>
###xml 1869 1873 1869 1873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2005</xref>
###xml 667 672 <span type="species:ncbi:10090">mouse</span>
###xml 1333 1337 <span type="species:ncbi:10090">mice</span>
Investigation of mast cell biology was severely hampered by the scarcity of these cells in tissues. Experimental systems that have widely been used are in vitro analysis of mast cell lines or mast cells differentiated in vitro from bone marrow (BMMC). In vivo analysis of the function of genes in mast cells until today relied on the reconstitution of mast cell-deficient rodents with mast cells derived from bone marrow or hematopoietic cells of gene-deficient animals or from gene-deficient embryonic stem cells (Kitamura et al. 1978; Nakano et al. 1985; Tsai et al. 2002, 2000). These systems yielded valuable information, but suffer important limitations. In the mouse lines kitW/W-v and kitW-sh/W-sh, which are commonly used for reconstitution experiments, spontaneous mutations of the kit gene coding region or its regulatory elements result in reduced activity of the kit receptor that controls development and survival of mast cells (Galli et al. 2005b; Grimbaldeston et al. 2005). In addition to mast cell-deficiency, kitW/W-vanimals are characterized by sterility, anemia, absence of melanocytes and interstitial cells of Cajal, a high incidence of dermatitis, papillomas of the forestomach, gastric ulcers and dilation of the duodenum (Galli et al. 2005b). kitW-sh animals, which lately are being used instead of kitW/W-v mice, seem to feature a more narrow defect with deficiency for mast cells, melanocytes, and interstitial cells of Cajal (Grimbaldeston et al. 2005). The transfer of in vitro cultivated mast cells into mast cell-deficient animals by intradermal, intraperitoneal or intravenous injections can result in mast cell numbers, which, dependent on the route of cell transfer and the anatomical site, can approach normal mast cell density, but often remain considerably lower with significant variability (Grimbaldeston et al. 2005; Tsai et al. 2005).
###end p 5
###begin p 6
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">1996</xref>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">1994</xref>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
The Cre/loxP recombination system represents a powerful tool that allows for conditional, e.g. cell type-specific, inactivation of genes in the mouse (Rajewsky et al. 1996). Since the first description of in vivo mutagenesis using the Cre/loxP system (Gu et al. 1994), an impressive number of floxed mouse lines has been generated. Herein, we report the first Cre transgenic line allowing mast cell-specific gene inactivation in vivo.
###end p 6
###begin title 7
Material and methods
###end title 7
###begin title 8
###xml 48 63 <span type="species:ncbi:10090">transgenic mice</span>
Construction of the transgene and generation of transgenic mice
###end title 8
###begin p 9
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2000</xref>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">1998</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 650 653 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 655 656 655 656 <underline xmlns:xlink="http://www.w3.org/1999/xlink">i</underline>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2002</xref>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 770 773 770 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 810 815 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxm2</italic>
###xml 854 857 854 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 923 928 923 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 967 970 967 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 1221 1224 1221 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 1248 1253 1248 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 1270 1271 1270 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1331 1334 1331 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 1349 1354 1349 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 1366 1373 1366 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre-Neo</italic>
###xml 1426 1429 1426 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1512 1517 1512 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 1560 1563 1560 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 1652 1656 1652 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">2004</xref>
###xml 1740 1743 1740 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1929 1938 1929 1938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 2138 2142 2138 2142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 2327 2334 2327 2334 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 2334 2401 2334 2401 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="10">Primers used for transgene construction by homologous recombination</p>
###xml 2334 2401 2334 2401 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="10">Primers used for transgene construction by homologous recombination</p></caption>
###xml 2401 2401 2401 2401 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="11248_2007_9153_Figa_HTML.gif" id="N0x1c74d10N0x2f6dd00"/>
###xml 2401 2401 2401 2401 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2"><inline-graphic xlink:href="11248_2007_9153_Figa_HTML.gif" id="N0x1c74d10N0x2f6dd00"/></td>
###xml 2401 2401 2401 2401 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="2"><inline-graphic xlink:href="11248_2007_9153_Figa_HTML.gif" id="N0x1c74d10N0x2f6dd00"/></td></tr>
###xml 2401 2401 2401 2401 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="2"><inline-graphic xlink:href="11248_2007_9153_Figa_HTML.gif" id="N0x1c74d10N0x2f6dd00"/></td></tr></tbody>
###xml 2401 2401 2401 2401 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2"><inline-graphic xlink:href="11248_2007_9153_Figa_HTML.gif" id="N0x1c74d10N0x2f6dd00"/></td></tr></tbody></table>
###xml 2401 2622 2401 2622 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="11">Oligonucleotides used for transgene construction by homologous recombination. The respective 50&#160;bp homology regions (HR) were included into the primers used for the amplification of selection markers or the minimal vector</p>
###xml 2401 2622 2401 2622 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="11">Oligonucleotides used for transgene construction by homologous recombination. The respective 50&#160;bp homology regions (HR) were included into the primers used for the amplification of selection markers or the minimal vector</p></table-wrap-foot>
###xml 2327 2622 2327 2622 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="10">Primers used for transgene construction by homologous recombination</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2"><inline-graphic xlink:href="11248_2007_9153_Figa_HTML.gif" id="N0x1c74d10N0x2f6dd00"/></td></tr></tbody></table><table-wrap-foot><p textid="11">Oligonucleotides used for transgene construction by homologous recombination. The respective 50&#160;bp homology regions (HR) were included into the primers used for the amplification of selection markers or the minimal vector</p></table-wrap-foot></table-wrap>
###xml 2622 2628 2622 2628 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 2923 2926 2923 2926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 3036 3041 3036 3041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 3084 3087 3084 3087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 3103 3108 3103 3108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxm2</italic>
###xml 3207 3210 3207 3210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 3239 3246 3239 3246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 3249 3252 3249 3252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 3258 3262 3258 3262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 2628 3350 2628 3350 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="12">Strategy of transgene construction. The BAC RP23-284A14 was shortened by replacing 51.3&#160;kb of insert DNA at the T7 end of the vector backbone and 42.4&#160;kb at the SP6 end by an ampicillin (Amp) and zeocin (Zeo) resistance cassette, respectively, resulting in a residual insert length of 129&#160;kb. A <italic>Not</italic>I restriction site was inserted along with each of the resistance genes. The coding part of the first exon of <italic>Mcpt5</italic> was replaced by a cassette comprising the <italic>Cre</italic> cassette and a <italic>loxm2</italic>-flanked neomycin resistance cassette (Neo) by homologous recombination and subsequent deletion of <italic>neo</italic> by Cre-mediated deletion in <italic>E. coli</italic>. (<italic>Not</italic>I, N, <italic>EcoR</italic>I, I, arrows represent open reading frames, shaded boxes represent untranslated regions)</p>
###xml 2628 3350 2628 3350 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="12">Strategy of transgene construction. The BAC RP23-284A14 was shortened by replacing 51.3&#160;kb of insert DNA at the T7 end of the vector backbone and 42.4&#160;kb at the SP6 end by an ampicillin (Amp) and zeocin (Zeo) resistance cassette, respectively, resulting in a residual insert length of 129&#160;kb. A <italic>Not</italic>I restriction site was inserted along with each of the resistance genes. The coding part of the first exon of <italic>Mcpt5</italic> was replaced by a cassette comprising the <italic>Cre</italic> cassette and a <italic>loxm2</italic>-flanked neomycin resistance cassette (Neo) by homologous recombination and subsequent deletion of <italic>neo</italic> by Cre-mediated deletion in <italic>E. coli</italic>. (<italic>Not</italic>I, N, <italic>EcoR</italic>I, I, arrows represent open reading frames, shaded boxes represent untranslated regions)</p></caption>
###xml 3350 3350 3350 3350 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2007_9153_Fig1_HTML" id="MO1"/>
###xml 2622 3350 2622 3350 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="12">Strategy of transgene construction. The BAC RP23-284A14 was shortened by replacing 51.3&#160;kb of insert DNA at the T7 end of the vector backbone and 42.4&#160;kb at the SP6 end by an ampicillin (Amp) and zeocin (Zeo) resistance cassette, respectively, resulting in a residual insert length of 129&#160;kb. A <italic>Not</italic>I restriction site was inserted along with each of the resistance genes. The coding part of the first exon of <italic>Mcpt5</italic> was replaced by a cassette comprising the <italic>Cre</italic> cassette and a <italic>loxm2</italic>-flanked neomycin resistance cassette (Neo) by homologous recombination and subsequent deletion of <italic>neo</italic> by Cre-mediated deletion in <italic>E. coli</italic>. (<italic>Not</italic>I, N, <italic>EcoR</italic>I, I, arrows represent open reading frames, shaded boxes represent untranslated regions)</p></caption><graphic position="anchor" xlink:href="11248_2007_9153_Fig1_HTML" id="MO1"/></fig>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
###xml 341 348 <span type="species:ncbi:562">E. coli</span>
###xml 1939 1954 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2073 2077 <span type="species:ncbi:10090">mice</span>
###xml 2168 2172 <span type="species:ncbi:10090">mice</span>
###xml 3239 3246 <span type="species:ncbi:562">E. coli</span>
The construct was based on a bacterial artificial chromosome (BAC) encompassing the entire Mcpt5 gene. The BAC clone RP23-284A14 from the mouse BAC library RPCI-23 (Osoegawa et al. 2000) was obtained from RZPD (Deutsches Ressourcenzentrum fur Genomforschung GmbH, Berlin, Germany). All modifications were done by homologous recombination in E. coli (Zhang et al. 1998) and sequences of all oligonucleotides used for construction by homologous recombination are listed in Table 1. Neighbouring genes contained in the BAC were excluded by replacing several kb of DNA at both ends of the insert by resistance genes (Fig. 1). In a next step, a modified iCre (improved Cre, Shimshek et al. 2002) gene cassette (Testa et al. unpublished) was inserted into the Mcpt5 gene. The Cre cassette was first assembled with a loxm2-flanked neomycin-resistance cassette (neo) and flanked by homology regions (HR) for recombination into the Mcpt5 gene. This was done by subcloning the Cre cDNA into a minimal vector consisting of the origin of replication and a chloramphenicol resistance gene amplified from pACYC184 (New England Biolabs, Frankfurt, Germany). The primers used for the amplification contain the HRs for both subcloning of Cre and insertion into the Mcpt5 gene (see Table 1). In a next step, the neomycin cassette was inserted 3' of Cre and 5' of the Mcpt5 HR. The HR-Cre-Neo-HR cassette was released from the minimal vector by NotI digestion and recombined into the BAC replacing the coding part of exon 1 of the Mcpt5 gene followed by Cre-mediated deletion of neo. The construct was purified for pronucleus injection as described by Sparwasser et al. (2004) with modifications. Briefly, the construct was separated from the BAC backbone by NotI digest and purified by gel electrophoresis and electroelution. Pronucleus injection was done by R. Naumann, MPI of Molecular Cell Biology and Genetics, Dresden, Germany. Genotyping of Mcpt5-Cre transgenic mice was performed by PCR (primers: Mcpt5-CreFor 5'ACAGTGGTATTCCCGGGGAGTGT, Mcpt5-CreRev 5' GTCAGTGCGTTCAAAGGCCA). Founder mice were bred to the ROSA26-EYFP reporter line (Srinivas et al. 2001) and five to 15 week old mice were analyzed for reporter gene expression. Animals were housed under SPF conditions and all experiments were done according to institutional guidelines. Table 1Primers used for transgene construction by homologous recombinationOligonucleotides used for transgene construction by homologous recombination. The respective 50 bp homology regions (HR) were included into the primers used for the amplification of selection markers or the minimal vectorFig. 1Strategy of transgene construction. The BAC RP23-284A14 was shortened by replacing 51.3 kb of insert DNA at the T7 end of the vector backbone and 42.4 kb at the SP6 end by an ampicillin (Amp) and zeocin (Zeo) resistance cassette, respectively, resulting in a residual insert length of 129 kb. A NotI restriction site was inserted along with each of the resistance genes. The coding part of the first exon of Mcpt5 was replaced by a cassette comprising the Cre cassette and a loxm2-flanked neomycin resistance cassette (Neo) by homologous recombination and subsequent deletion of neo by Cre-mediated deletion in E. coli. (NotI, N, EcoRI, I, arrows represent open reading frames, shaded boxes represent untranslated regions)
###end p 9
###begin p 10
Primers used for transgene construction by homologous recombination
###end p 10
###begin p 11
Oligonucleotides used for transgene construction by homologous recombination. The respective 50 bp homology regions (HR) were included into the primers used for the amplification of selection markers or the minimal vector
###end p 11
###begin p 12
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxm2</italic>
###xml 579 582 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 611 618 611 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 621 624 621 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 630 634 630 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 611 618 <span type="species:ncbi:562">E. coli</span>
Strategy of transgene construction. The BAC RP23-284A14 was shortened by replacing 51.3 kb of insert DNA at the T7 end of the vector backbone and 42.4 kb at the SP6 end by an ampicillin (Amp) and zeocin (Zeo) resistance cassette, respectively, resulting in a residual insert length of 129 kb. A NotI restriction site was inserted along with each of the resistance genes. The coding part of the first exon of Mcpt5 was replaced by a cassette comprising the Cre cassette and a loxm2-flanked neomycin resistance cassette (Neo) by homologous recombination and subsequent deletion of neo by Cre-mediated deletion in E. coli. (NotI, N, EcoRI, I, arrows represent open reading frames, shaded boxes represent untranslated regions)
###end p 12
###begin title 13
Flow cytometric analysis
###end title 13
###begin p 14
Total splenocyte suspensions were separated into lymphocyte and non-lymphocyte fractions by magnetic cell sorting (MACS, Miltenyi Biotec, Bergisch Gladbach, Germany) using anti-CD3-Biotin (clone 145-2C11, BD Pharmingen), anti-Biotin MicroBeads, anti-CD19 MicroBeads and LS MACS columns (Miltenyi Biotec). Skin cell suspensions were prepared from shaved abdominal skin plus one ear pinna by mincing followed by an incubation with 2 mg/ml collagenase IV (Worthington Biochem. Corporation, Lakewood, NJ, USA) at 37degreesC. Cells in peritoneal lavage as well as single cell suspensions from skin and spleen were stained with phycoerythrin (PE)-conjugated anti-CD3 (clone 145-2C11), anti-CD19 (clone 1D3); anti-CD11c (clone HL3), anti-CD45 (clone 30-F11) and anti-Siglec-F (clone E50-2440) (all from BD Pharmingen) or anti-FcepsilonRIalpha-PE (clone MAR-1), allophycocyanin (APC)-conjugated anti-CD117 (clone 2B8) and anti-CD49b (clone Dx5), F4/80-Biotin (clone BM8) and streptavidin-PE (all from eBiosciences, SanDiego, CA) or anti-Gr-1-PE (clone RB6-8C5) (Miltenyi Biotech). The cells were analyzed on a FACSCalibur (BD Biosciences).
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 40 55 <span type="species:ncbi:10090">transgenic mice</span>
Transgene construction and screening of transgenic mice for Cre expression
###end title 16
###begin p 17
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 478 481 478 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 555 564 555 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 760 766 760 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26</italic>
###xml 813 817 813 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 840 849 840 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 849 855 849 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26</italic>
###xml 856 860 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EYFP</italic>
###xml 988 989 988 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1433 1439 1433 1439 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1615 1636 1615 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 1901 1922 1891 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 1979 1983 1969 1973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre-</italic>
###xml 1996 2007 1986 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26-EYFP</italic>
###xml 1439 2056 1439 2046 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18">Efficiency of Cre-mediated reporter gene activation in mast cells. EYFP expression is demonstrated in cells from peritoneal lavage fluid and single cell suspensions of skin of <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice. Peritoneal mast cells were stained for CD117 and Fc&#949;RI&#945; (n&#160;=&#160;7) and skin mast cells for CD117 and CD45 (n&#160;=&#160;4). Mast cell populations were gated and their EYFP fluorescence displayed in histogram plots. The black graph represents <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice, the shaded graph represents the <italic>Cre-</italic>negative but <italic>ROSA26-EYFP</italic>-positive control (littermates in most instances)</p>
###xml 1439 2056 1439 2046 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18">Efficiency of Cre-mediated reporter gene activation in mast cells. EYFP expression is demonstrated in cells from peritoneal lavage fluid and single cell suspensions of skin of <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice. Peritoneal mast cells were stained for CD117 and Fc&#949;RI&#945; (n&#160;=&#160;7) and skin mast cells for CD117 and CD45 (n&#160;=&#160;4). Mast cell populations were gated and their EYFP fluorescence displayed in histogram plots. The black graph represents <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice, the shaded graph represents the <italic>Cre-</italic>negative but <italic>ROSA26-EYFP</italic>-positive control (littermates in most instances)</p></caption>
###xml 2056 2056 2046 2046 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2007_9153_Fig2_HTML" id="MO2"/>
###xml 1433 2056 1433 2046 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="18">Efficiency of Cre-mediated reporter gene activation in mast cells. EYFP expression is demonstrated in cells from peritoneal lavage fluid and single cell suspensions of skin of <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice. Peritoneal mast cells were stained for CD117 and Fc&#949;RI&#945; (n&#160;=&#160;7) and skin mast cells for CD117 and CD45 (n&#160;=&#160;4). Mast cell populations were gated and their EYFP fluorescence displayed in histogram plots. The black graph represents <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice, the shaded graph represents the <italic>Cre-</italic>negative but <italic>ROSA26-EYFP</italic>-positive control (littermates in most instances)</p></caption><graphic position="anchor" xlink:href="11248_2007_9153_Fig2_HTML" id="MO2"/></fig>
###xml 291 306 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1644 1659 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1930 1945 <span type="species:ncbi:10090">transgenic mice</span>
In order to drive Cre expression in mast cells, we used a BAC clone containing the entire Mcpt5 gene along with abundant upstream and downstream flanking DNA (Fig. 1). Neighboring genes were excluded by shortening the BAC on both ends to avoid possible effects of altered gene dosage in the transgenic mice. In a next step, the coding part of the first exon of Mcpt5 was replaced by the Cre cassette (see Methods and Fig. 1). The construct was released from the BAC backbone by NotI digest (Fig. 1) and injected into the pronuclei of C57BL/6 oocytes. Six Mcpt5-Cre transgenic founder animals were obtained and mated to a ROSA26 reporter line (Srinivas et al. 2001) which expresses enhanced yellow fluorescent protein (EYFP) under the control of the ubiquitous ROSA26 promoter following Cre-mediated deletion of a loxP-flanked stop element. Mcpt5-CreROSA26-EYFP double transgenic animals were analyzed for EYFP expression in peritoneal and skin mast cells by FACS as described below (Fig. 2). Reporter gene expression was detected in mast cells from three of the six founder lines. One of these lines showed EYFP expression in only 80% of peritoneal mast cells and was not investigated further. Close to 100% of peritoneal mast cells were EYFP positive in two lines, which, because of autosomal inheritance of the transgene in one line and X-linked inheritance in the other, were called "A-Mcpt5-Cre" and "X-Mcpt5-Cre", respectively. Fig. 2Efficiency of Cre-mediated reporter gene activation in mast cells. EYFP expression is demonstrated in cells from peritoneal lavage fluid and single cell suspensions of skin of Mcpt5-Cre ROSA26-EYFP double transgenic mice. Peritoneal mast cells were stained for CD117 and FcepsilonRIalpha (n = 7) and skin mast cells for CD117 and CD45 (n = 4). Mast cell populations were gated and their EYFP fluorescence displayed in histogram plots. The black graph represents Mcpt5-Cre ROSA26-EYFP double transgenic mice, the shaded graph represents the Cre-negative but ROSA26-EYFP-positive control (littermates in most instances)
###end p 17
###begin p 18
###xml 176 197 176 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 462 483 452 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 540 544 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre-</italic>
###xml 557 568 547 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26-EYFP</italic>
###xml 205 220 <span type="species:ncbi:10090">transgenic mice</span>
###xml 491 506 <span type="species:ncbi:10090">transgenic mice</span>
Efficiency of Cre-mediated reporter gene activation in mast cells. EYFP expression is demonstrated in cells from peritoneal lavage fluid and single cell suspensions of skin of Mcpt5-Cre ROSA26-EYFP double transgenic mice. Peritoneal mast cells were stained for CD117 and FcepsilonRIalpha (n = 7) and skin mast cells for CD117 and CD45 (n = 4). Mast cell populations were gated and their EYFP fluorescence displayed in histogram plots. The black graph represents Mcpt5-Cre ROSA26-EYFP double transgenic mice, the shaded graph represents the Cre-negative but ROSA26-EYFP-positive control (littermates in most instances)
###end p 18
###begin title 19
Efficient and mast cell-specific Cre-mediated recombination in the lines A-Mcpt5-Cre and X-Mcpt5-Cre
###end title 19
###begin p 20
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 128 130 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 150 173 140 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-Mcpt5-Cre ROSA26-EYFP</italic>
###xml 236 237 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 372 373 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 377 379 367 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 636 637 616 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 641 643 621 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 730 731 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1056 1060 <span type="species:ncbi:10090">mice</span>
Highly efficient Cre-mediated activation of reporter gene expression was uniformly observed in peritoneal CD117+FcepsilonRIalpha+ mast cells of seven A-Mcpt5-Cre ROSA26-EYFP double transgenic animals (98.7-99.6%, on average 99.1%, Fig. 2). In skin cell suspensions mast cells were detected in extremely low numbers, on average 0.32%. (Skin mast cells were defined as CD117+CD45+ cells. A staining of FcepsilonRIalpha on skin mast cells was not reliable in our hands, likely due to loss of epitopes after enzymatic tissue digestion). In the five animals for which this mast cell population was investigated, the majority of the few CD117+CD45+ cells gated was EYFP positive (43/47, 54/64, 32/39, 23/27 and 77/88 gated events, Fig. 2). Given that the mast cell gate will inevitably collect also some non-mast cells upon analysis of high total cell numbers (40,000 events), the percentage of skin mast cells expressing EYFP is probably close to 100%. A similar efficiency of Cre-mediated activation of the reporter gene was observed in three male X-Mcpt5-Cre mice (not shown) whereas the two female animals analyzed showed EYFP fluorescence in only 61% and 32% of peritoneal mast cells consistent with random X-chromosome inactivation (not shown).
###end p 20
###begin p 21
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 627 636 627 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 1041 1046 1041 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 1057 1063 1057 1063 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1256 1277 1256 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 1736 1757 1720 1741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 1814 1818 1798 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre-</italic>
###xml 1831 1842 1815 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26-EYFP</italic>
###xml 1063 1891 1063 1875 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="22">Absence of EYFP reporter gene expression in hematopoietic cells other than mast cells. EYFP expression was analyzed in hematopoietic cells from peritoneal lavage and spleen cell suspensions of <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice. In order to enrich granulocytes, splenocytes were separated into a lymphocyte and non-lymphocyte fraction by MACS. Basophils were double stained for CD49b and Fc&#949;RI&#945;. Macrophages, dendritic cells, neutrophils, eosinophils, B cells and T cells were stained for F4/80, CD11c, Gr-1, Siglec-F, CD19 and CD3&#949;, respectively. The respective populations were gated and displayed in histogram plots. The black graph represents <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice, the shaded graph represents the <italic>Cre-</italic>negative but <italic>ROSA26-EYFP</italic>-positive control (littermates in most instances)</p>
###xml 1063 1891 1063 1875 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="22">Absence of EYFP reporter gene expression in hematopoietic cells other than mast cells. EYFP expression was analyzed in hematopoietic cells from peritoneal lavage and spleen cell suspensions of <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice. In order to enrich granulocytes, splenocytes were separated into a lymphocyte and non-lymphocyte fraction by MACS. Basophils were double stained for CD49b and Fc&#949;RI&#945;. Macrophages, dendritic cells, neutrophils, eosinophils, B cells and T cells were stained for F4/80, CD11c, Gr-1, Siglec-F, CD19 and CD3&#949;, respectively. The respective populations were gated and displayed in histogram plots. The black graph represents <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice, the shaded graph represents the <italic>Cre-</italic>negative but <italic>ROSA26-EYFP</italic>-positive control (littermates in most instances)</p></caption>
###xml 1891 1891 1875 1875 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2007_9153_Fig3_HTML" id="MO3"/>
###xml 1057 1891 1057 1875 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="22">Absence of EYFP reporter gene expression in hematopoietic cells other than mast cells. EYFP expression was analyzed in hematopoietic cells from peritoneal lavage and spleen cell suspensions of <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice. In order to enrich granulocytes, splenocytes were separated into a lymphocyte and non-lymphocyte fraction by MACS. Basophils were double stained for CD49b and Fc&#949;RI&#945;. Macrophages, dendritic cells, neutrophils, eosinophils, B cells and T cells were stained for F4/80, CD11c, Gr-1, Siglec-F, CD19 and CD3&#949;, respectively. The respective populations were gated and displayed in histogram plots. The black graph represents <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice, the shaded graph represents the <italic>Cre-</italic>negative but <italic>ROSA26-EYFP</italic>-positive control (littermates in most instances)</p></caption><graphic position="anchor" xlink:href="11248_2007_9153_Fig3_HTML" id="MO3"/></fig>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 724 728 <span type="species:ncbi:10090">mice</span>
###xml 818 823 <span type="species:ncbi:10090">mouse</span>
###xml 1285 1300 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1765 1780 <span type="species:ncbi:10090">transgenic mice</span>
In both lines, Cre-mediated activation of EYFP expression was specific for mast cells. In seven A-Mcpt5-Cre and three male X-Mcpt5-Cre animals we detected no or only minimal numbers (i.e. below 1%) of EYFP positive cells (below 3% in one A-Mcpt5-Cre animal) in hematopoietic populations other than mast cells (Fig. 3) or in non-hematopoietic cells of the skin cell suspensions (primarily keratinocytes and fibroblasts, not shown). As a control, we used mice with germline deletion of the stop element of the ROSA26-EYFP Cre excision reporter demonstrating that all non-mast cell populations analysed for reporter expression in Mcpt5-Cre mice can, in principle, express EYFP (not shown). In contrast to the seven A-Mcpt5-Cre mice (described above) showing mast cell-specific Cre-mediated recombination, one A-Mcpt5-Cre mouse displayed non-specific reporter gene expression in 15-25% of all cell types analyzed including non-hematopoietic cells of the skin (not shown). This finding likely reflects accidental early activity of the transgenic Mcpt5 promoter. Fig. 3Absence of EYFP reporter gene expression in hematopoietic cells other than mast cells. EYFP expression was analyzed in hematopoietic cells from peritoneal lavage and spleen cell suspensions of Mcpt5-Cre ROSA26-EYFP double transgenic mice. In order to enrich granulocytes, splenocytes were separated into a lymphocyte and non-lymphocyte fraction by MACS. Basophils were double stained for CD49b and FcepsilonRIalpha. Macrophages, dendritic cells, neutrophils, eosinophils, B cells and T cells were stained for F4/80, CD11c, Gr-1, Siglec-F, CD19 and CD3epsilon, respectively. The respective populations were gated and displayed in histogram plots. The black graph represents Mcpt5-Cre ROSA26-EYFP double transgenic mice, the shaded graph represents the Cre-negative but ROSA26-EYFP-positive control (littermates in most instances)
###end p 21
###begin p 22
###xml 193 214 193 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 673 694 657 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 751 755 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre-</italic>
###xml 768 779 752 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26-EYFP</italic>
###xml 222 237 <span type="species:ncbi:10090">transgenic mice</span>
###xml 702 717 <span type="species:ncbi:10090">transgenic mice</span>
Absence of EYFP reporter gene expression in hematopoietic cells other than mast cells. EYFP expression was analyzed in hematopoietic cells from peritoneal lavage and spleen cell suspensions of Mcpt5-Cre ROSA26-EYFP double transgenic mice. In order to enrich granulocytes, splenocytes were separated into a lymphocyte and non-lymphocyte fraction by MACS. Basophils were double stained for CD49b and FcepsilonRIalpha. Macrophages, dendritic cells, neutrophils, eosinophils, B cells and T cells were stained for F4/80, CD11c, Gr-1, Siglec-F, CD19 and CD3epsilon, respectively. The respective populations were gated and displayed in histogram plots. The black graph represents Mcpt5-Cre ROSA26-EYFP double transgenic mice, the shaded graph represents the Cre-negative but ROSA26-EYFP-positive control (littermates in most instances)
###end p 22
###begin title 23
Absence of significant Cre-mediated genotoxicity in mast cells of Mcpt5-Cre animals
###end title 23
###begin p 24
###xml 71 80 71 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 250 271 250 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 751 752 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 799 820 789 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre ROSA26-EYFP</italic>
###xml 1015 1024 1005 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 1154 1160 1144 1150 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1224 1233 1214 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 1252 1253 1242 1243 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1334 1343 1324 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 1422 1423 1412 1413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1439 1440 1419 1420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1457 1458 1437 1438 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1526 1548 1506 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-Mcpt5Cre ROSA26-EYFP</italic>
###xml 1701 1705 1681 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2007</xref>
###xml 1160 1915 1150 1895 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25">Numbers and proliferative potential of peritoneal mast cells in <italic>Mcpt5-Cre</italic> transgenic mice. (<bold>a</bold>) Mast cells were quantified in peritoneal lavage fluid from control (n&#160;=&#160;9) and <italic>Mcpt5-Cre</italic> (7 A-Mcpt5-Cre and 3 male X-Mcpt5-Cre) mice. Mast cells were detected as CD117<sup>+</sup>Fc&#949;RI&#945;<sup>+</sup> cells by FACS. (<bold>b</bold>) Total cells from peritoneal lavage fluid from one control and one <italic>A-Mcpt5Cre ROSA26-EYFP</italic> double transgenic mouse were incubated in complete Opti-MEM supplemented with 4% supernatant from CHO transfectants secreting murine SCF (Malbec et&#160;al. <xref ref-type="bibr" rid="CR15">2007</xref>). The CHO transfectants were generated by S. Lyman, Immunex, Seattle and were kindly provided by P. Dubreuil. Cell numbers were quantified at each passage every 3&#8211;4&#160;days by counting trypan blue-excluding cells</p>
###xml 1160 1915 1150 1895 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25">Numbers and proliferative potential of peritoneal mast cells in <italic>Mcpt5-Cre</italic> transgenic mice. (<bold>a</bold>) Mast cells were quantified in peritoneal lavage fluid from control (n&#160;=&#160;9) and <italic>Mcpt5-Cre</italic> (7 A-Mcpt5-Cre and 3 male X-Mcpt5-Cre) mice. Mast cells were detected as CD117<sup>+</sup>Fc&#949;RI&#945;<sup>+</sup> cells by FACS. (<bold>b</bold>) Total cells from peritoneal lavage fluid from one control and one <italic>A-Mcpt5Cre ROSA26-EYFP</italic> double transgenic mouse were incubated in complete Opti-MEM supplemented with 4% supernatant from CHO transfectants secreting murine SCF (Malbec et&#160;al. <xref ref-type="bibr" rid="CR15">2007</xref>). The CHO transfectants were generated by S. Lyman, Immunex, Seattle and were kindly provided by P. Dubreuil. Cell numbers were quantified at each passage every 3&#8211;4&#160;days by counting trypan blue-excluding cells</p></caption>
###xml 1915 1915 1895 1895 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2007_9153_Fig4_HTML" id="MO4"/>
###xml 1154 1915 1144 1895 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="25">Numbers and proliferative potential of peritoneal mast cells in <italic>Mcpt5-Cre</italic> transgenic mice. (<bold>a</bold>) Mast cells were quantified in peritoneal lavage fluid from control (n&#160;=&#160;9) and <italic>Mcpt5-Cre</italic> (7 A-Mcpt5-Cre and 3 male X-Mcpt5-Cre) mice. Mast cells were detected as CD117<sup>+</sup>Fc&#949;RI&#945;<sup>+</sup> cells by FACS. (<bold>b</bold>) Total cells from peritoneal lavage fluid from one control and one <italic>A-Mcpt5Cre ROSA26-EYFP</italic> double transgenic mouse were incubated in complete Opti-MEM supplemented with 4% supernatant from CHO transfectants secreting murine SCF (Malbec et&#160;al. <xref ref-type="bibr" rid="CR15">2007</xref>). The CHO transfectants were generated by S. Lyman, Immunex, Seattle and were kindly provided by P. Dubreuil. Cell numbers were quantified at each passage every 3&#8211;4&#160;days by counting trypan blue-excluding cells</p></caption><graphic position="anchor" xlink:href="11248_2007_9153_Fig4_HTML" id="MO4"/></fig>
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 429 444 <span type="species:ncbi:10090">transgenic mice</span>
###xml 830 835 <span type="species:ncbi:10090">mouse</span>
###xml 1234 1249 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1383 1387 <span type="species:ncbi:10090">mice</span>
###xml 1567 1572 <span type="species:ncbi:10090">mouse</span>
###xml 1675 1681 <span type="species:ncbi:10090">murine</span>
In order to exclude a reduced proliferative potential of mast cells in Mcpt5-Cre transgenic mice due to Cre-mediated genotoxic effects, we compared the percentage of mast cells in peritoneal lavage and the proliferation of peritoneal mast cells from Mcpt5-Cre ROSA26-EYFP double transgenic or wild-type mice in vitro. Cell suspensions obtained by peritoneal lavage contained similar numbers of mast cells in wild-type and double transgenic mice (Fig. 4a). Total peritoneal lavage cells were cultured in the presence of stem cell factor. After 23 days, these cultures contained 98% mast cells as judged by expression of CD117 and FcepsilonRIalpha (not shown). By this time, absolute cell numbers had increased more than 200-fold in both cultures (Fig. 4b). Importantly, the mast cells grown from the Mcpt5-Cre ROSA26-EYFP positive mouse uniformly expressed EYFP (not shown) ruling out an overgrowth of the culture by a (hypothetical) minor population of mast cells, which do not express Cre. These results show that Mcpt5-Cre positive mast cells are not growth retarded and therefore do not seem to be significantly affected by Cre-mediated genotoxicity. Fig. 4Numbers and proliferative potential of peritoneal mast cells in Mcpt5-Cre transgenic mice. (a) Mast cells were quantified in peritoneal lavage fluid from control (n = 9) and Mcpt5-Cre (7 A-Mcpt5-Cre and 3 male X-Mcpt5-Cre) mice. Mast cells were detected as CD117+FcepsilonRIalpha+ cells by FACS. (b) Total cells from peritoneal lavage fluid from one control and one A-Mcpt5Cre ROSA26-EYFP double transgenic mouse were incubated in complete Opti-MEM supplemented with 4% supernatant from CHO transfectants secreting murine SCF (Malbec et al. 2007). The CHO transfectants were generated by S. Lyman, Immunex, Seattle and were kindly provided by P. Dubreuil. Cell numbers were quantified at each passage every 3-4 days by counting trypan blue-excluding cells
###end p 24
###begin p 25
###xml 64 73 64 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 174 183 174 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 279 280 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 297 298 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 366 388 356 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-Mcpt5Cre ROSA26-EYFP</italic>
###xml 541 545 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2007</xref>
###xml 74 89 <span type="species:ncbi:10090">transgenic mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 515 521 <span type="species:ncbi:10090">murine</span>
Numbers and proliferative potential of peritoneal mast cells in Mcpt5-Cre transgenic mice. (a) Mast cells were quantified in peritoneal lavage fluid from control (n = 9) and Mcpt5-Cre (7 A-Mcpt5-Cre and 3 male X-Mcpt5-Cre) mice. Mast cells were detected as CD117+FcepsilonRIalpha+ cells by FACS. (b) Total cells from peritoneal lavage fluid from one control and one A-Mcpt5Cre ROSA26-EYFP double transgenic mouse were incubated in complete Opti-MEM supplemented with 4% supernatant from CHO transfectants secreting murine SCF (Malbec et al. 2007). The CHO transfectants were generated by S. Lyman, Immunex, Seattle and were kindly provided by P. Dubreuil. Cell numbers were quantified at each passage every 3-4 days by counting trypan blue-excluding cells
###end p 25
###begin title 26
Discussion
###end title 26
###begin p 27
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
Here, we describe a novel Cre transgenic mouse allowing mast cell-specific knock out of genes in vivo. We employed BAC transgene technology to express a Cre cassette under the control of the Mcpt5 promoter. To our knowledge, this is the first report of mast cell-specific Cre-mediated recombination in the mouse.
###end p 27
###begin p 28
###xml 248 253 248 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2005b</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2005</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">1978</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2005</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2005</xref>
###xml 550 553 550 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
To date, important insights into functions of mast cells have been gained by reconstitution of mast cell-deficient mice with mast cells differentiated in vitro from gene deficient bone marrow or embryonic and hematopoietic stem cells (Galli et al. 2005b; Grimbaldeston et al. 2005; Kitamura et al. 1978; Tsai et al. 2005). While this model yielded important information, inherent technical problems limit experimentation and interpretation of data in this system (Tsai et al. 2005). We expect that mast cell-specific knock out of genes using our new Cre transgenic line will greatly facilitate investigation of mast cell biology.
###end p 28
###begin p 29
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 218 219 218 219 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5</italic>
###xml 616 617 616 617 <underline xmlns:xlink="http://www.w3.org/1999/xlink">X</underline>
The two Cre transgenic lines demonstrate that the Mcpt5-promoter allows efficient and cell type-specific expression of a Cre transgene inserted into the first exon. One animal of the line A-Mcpt5-Cre (characterized by autosomal transgene inheritance) showed non-specific Cre-mediated recombination in non-mast cells while seven animals of this line did not. This finding likely reflects accidental early activity of the transgenic Mcpt5 promoter, e.g. in one stem cell during the embryonic four cell stage. Future analysis will define the frequency of such events more precisely. In females of the X-Mcpt5-Cre line (X-chromosomal inheritance), Cre-mediated recombination occurred in only about half of the mast cells due to inactivation of the transgene-carrying X-chromosome. Incomplete inactivation of particular genes may be advantageous if the attenuation of a severe phenotype is desired.
###end p 29
###begin p 30
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2007</xref>
###xml 234 243 234 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcpt5-Cre</italic>
###xml 334 341 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
Cre recombinase has been shown to mediate genotoxicity in some Cre transgenic or Cre knock in mouse strains resulting in a reduced proliferative potential or even death of Cre expressing cells (Schmidt-Supprian and Rajewsky 2007). In Mcpt5-Cre mice, however, we found no difference in mast cell numbers or proliferation of mast cells ex vivo in response to stem cell factor indicating that Cre-mediated genome damage is not a prominent feature of these mice.
###end p 30
###begin p 31
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2005</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
We are currently refining our system further to achieve also inducible mast cell-specific gene inactivation in adult mice. In addition, we are breeding the new lines to iDTR mice (Buch et al. 2005) aiming at diphtheria toxin-inducible ablation of the mast cell lineage in adult animals.
###end p 31
###begin title 32
Acknowledgements
###end title 32
###begin p 33
The authors wish to thank Tobias Haering and Carmen Berns for excellent technical assistance. We thank Dr. P. Dubreuil for providing SCF producing CHO transfectants.
###end p 33
###begin title 34
References
###end title 34
###begin article-title 35
Mast cells: not only in allergy
###end article-title 35
###begin article-title 36
A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration
###end article-title 36
###begin article-title 37
New and emerging roles for mast cells in host defense
###end article-title 37
###begin article-title 38
Critical protective role of mast cells in a model of acute septic peritonitis
###end article-title 38
###begin article-title 39
Mast cells as "tunable" effector and immunoregulatory cells: recent advances
###end article-title 39
###begin article-title 40
Mast cells in the development of adaptive immune responses
###end article-title 40
###begin article-title 41
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo
###end article-title 41
###begin article-title 42
Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting
###end article-title 42
###begin article-title 43
Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation
###end article-title 43
###begin article-title 44
Regulation of mast-cell and basophil function and survival by IgE
###end article-title 44
###begin article-title 45
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
###end article-title 45
###begin article-title 46
Mast cells: a cellular link between autoantibodies and inflammatory arthritis
###end article-title 46
###begin article-title 47
Mast cells are essential intermediaries in regulatory T-cell tolerance
###end article-title 47
###begin article-title 48
Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha
###end article-title 48
###begin article-title 49
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells
###end article-title 49
###begin article-title 50
Mast cells in innate immunity
###end article-title 50
###begin article-title 51
Mast cells
###end article-title 51
###begin article-title 52
###xml 154 158 <span type="species:ncbi:10090">mice</span>
Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells
###end article-title 52
###begin article-title 53
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Bacterial artificial chromosome libraries for mouse sequencing and functional analysis
###end article-title 53
###begin article-title 54
Conditional gene targeting
###end article-title 54
###begin article-title 55
Vagaries of conditional gene targeting
###end article-title 55
###begin article-title 56
###xml 65 71 <span type="species:ncbi:10090">murine</span>
Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis
###end article-title 56
###begin article-title 57
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Codon-improved Cre recombinase (iCre) expression in the mouse
###end article-title 57
###begin article-title 58
###xml 91 106 <span type="species:ncbi:10090">transgenic mice</span>
General method for the modification of different BAC types and the rapid generation of BAC transgenic mice
###end article-title 58
###begin article-title 59
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
###end article-title 59
###begin article-title 60
Mast cells promote atherosclerosis by releasing proinflammatory cytokines
###end article-title 60
###begin article-title 61
###xml 32 37 <span type="species:ncbi:9606">human</span>
Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo
###end article-title 61
###begin article-title 62
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo
###end article-title 62
###begin article-title 63
Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo
###end article-title 63
###begin article-title 64
###xml 159 163 <span type="species:ncbi:10090">mice</span>
In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo
###end article-title 64
###begin article-title 65
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Mast cells are required for normal healing of skin wounds in mice
###end article-title 65
###begin article-title 66
###xml 55 71 <span type="species:ncbi:562">Escherichia coli</span>
A new logic for DNA engineering using recombination in Escherichia coli
###end article-title 66
###begin title 67
Abbreviations
###end title 67
###begin p 68
Bacterial artificial chromosome
###end p 68
###begin p 69
Bone marrow-derived mast cells
###end p 69
###begin p 70
Enhanced yellow fluorescent protein
###end p 70
###begin p 71
Fluorescence activated cell sorting
###end p 71
###begin p 72
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
loxP-flanked
###end p 72
###begin p 73
Kilobases
###end p 73
###begin p 74
Mast cell protease
###end p 74
###begin p 75
Homology region
###end p 75
###begin p 76
Magnetic activated cell sorting
###end p 76
###begin p 77
Neomycin resistance gene
###end p 77
###begin p 78
Stem cell factor
###end p 78
###begin p 79
###xml 0 5 <span type="species:ncbi:33453">Julia</span>
Julia Scholten and Karin Hartmann contributed equally to this work.
###end p 79
###begin p 80
Supported by grants from the German Research Counsil (Deutsche Forschungsgemeinschaft, RO 2133/2-2) to A.R. and K.H. and the Koeln Fortune Program/Faculty of Medicine, University of Cologne, to A.R. and K.H.. The authors have no conflict of interest
###end p 80

